Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance

被引：20

作者：

Veziris, N.

Martin, C.

Brossier, F.

Bonnaud, F.

Denis, F.

Aubry, A. ^{[1
]}

机构：

[1] Univ Paris 06, Fac Med Pierre & Marie Curie, Bacteriol Lab, F-75013 Paris, France

[2] Grp Hosp Pitie Salpetriere, AP HP, Ctr Natl Reference Resistance Mycobacteries & Res, F-75013 Paris, France

[3] CHU Dupuytren, Lab Bacteriol Virol Hyg, F-87000 Limoges, France

[4] CHU Dupuytren, Serv Pneumol, F-87000 Limoges, France

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2007年 / 26卷 / 06期

关键词：

D O I：

10.1007/s10096-007-0298-0

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：423 / 425

页数：3

共 10 条

[1]

[Anonymous], 2006, Weekly Epidemiological Record, V81, P430

[2] Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis [J].

Chan, ED ;

Laurel, V ;

Strand, MJ ;

Chan, JF ;

Huynh, MLN ;

Goble, M ;

Iseman, MD .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (10) :1103-1109

[3] FAILURE OF DRUG PENETRATION AND ACQUISITION OF DRUG-RESISTANCE IN CHRONIC TUBERCULOUS EMPYEMA [J].

ELLIOTT, AM ;

BERNING, SE ;

ISEMAN, MD ;

PELOQUIN, CA .

TUBERCLE AND LUNG DISEASE, 1995, 76 (05) :463-467

[4] Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria [J].

Guillemin, I ;

Jarlier, V ;

Cambau, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2084-2088

[5]

JARLIER V, 1984, PATHOL BIOL, V32, P399

[6] Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA [J].

Lemaitre, N ;

Sougakoff, W ;

Truffot-Pernot, C ;

Jarlier, V .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1761-1763

[7] Molecular analysis of cross-resistance to capreomycin, kanamycin, arnikacin, and viomycin in Mycobacterium tuberculosis [J].

Maus, CE ;

Plikaytis, BB ;

Shinnick, TM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3192-3197

[8]

*WHO, 2006, GUID PROGR MAN DRUG

[9]

Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301

[10] Global incidence of multidrug-resistant tuberculosis [J].

Zignol, Matteo ;

Hosseini, Mehran S. ;

Wright, Abigail ;

Lambregts-van Weezenbeek, Catharina ;

Nunn, Paul ;

Watt, Catherine J. ;

Williams, Brian G. ;

Dye, Christopher .

JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (04) :479-485

← 1 →